| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $204.3M | +19.9% |
| Cost of Revenue | $58.4M | +7.5% |
| Gross Profit | $145.9M | +25.7% |
| R&D Expense | $40.2M | +18.2% |
| SG&A Expense | $52.5M | +14.9% |
| Operating Income | -$31.4M | +8.6% |
| Interest Expense | $1.5M | -20.8% |
| Income Tax | $189K | -27.3% |
| Net Income | -$28.3M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $51.6M | +1.7% |
| Accounts Receivable | $3.7M | +6.6% |
| Current Assets | $120.7M | -7.0% |
| Total Assets | $188.9M | -6.0% |
| Current Liabilities | $76.6M | +5.2% |
| Total Liabilities | $122.0M | -0.1% |
| Stockholders' Equity | $67.0M | -15.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $14.1M | +38.4% |
| Capital Expenditures | $2.2M | +29.2% |
| Investing Cash Flow | $8.9M | +214.8% |
| Financing Cash Flow | -$22.2M | -61.7% |
| Free Cash Flow | $12.0M | +40.3% |
| +8.7% |
| EPS (Basic) | -$0.40 | +13.0% |
| EPS (Diluted) | -$0.40 | +13.0% |